[{"edinetCode":"E01047","endDate":"2016\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2994.0,"averageTemporaryStaff":570.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":38387000.0,"sharesOwendPercent":0.4513,"outstandingShares":null,"numberOfSubsidiary":36.0,"bps":1818.1,"equityRatio":0.712,"cashAndCashEquivalents":28322000000.0,"assets":201234000000.0,"currentAssets":128646000000.0,"fixedAsset":72587000000.0,"tangibleFixedAssets":17833000000.0,"intangibleFixedAssets":7223000000.0,"investmentAndOtherAssets":47529000000.0,"liabilities":57914000000.0,"currentLiabilities":46975000000.0,"shorTermDept":192000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10938000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":143320000000.0,"capitalStock":135221000000.0,"capital":3450000000.0,"capitalSurplus":4958000000.0,"accumulatedEarnings":147901000000.0,"treasuryStock":-21088000000.0,"valuationAndConversionAdjustments":8031000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":120051000000.0,"costOfSales":48638000000.0,"grossProfit":71412000000.0,"sgaExpenses":54003000000.0,"salaryAndBenefit":null,"depreciationAndSGA":525000000.0,"RDExpenses":4121000000.0,"operatingIncome":17409000000.0,"nonOperatingIncome":2946000000.0,"nonOperatingExpenses":855000000.0,"interestExpense":21000000.0,"ordinaryProfit":19499000000.0,"extraordinaryGain":1807000000.0,"extraordinaryLoss":1505000000.0,"incomeBeforeTax":19802000000.0,"incomeTaxes":5544000000.0,"netIncome":14257000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":14321000000.0,"comprehensiveIncome":13114000000.0,"eps":179.12,"dilutedEps":178.86,"dividendPerShare":null,"per":27.9,"roe":0.1,"cashFlowFromOperatingActivities":16097000000.0,"depreciationAndCashflowFromOperatingActivities":2112000000.0,"cashFlowFromInvestingActivities":-519000000.0,"cashFlowFromFinancialActivities":-11922000000.0,"changesInCashAndCashEquivalents":2894000000.0,"列1":"asr","submitDate":"2017\/3\/30","stockCode":4967,"accountingYear":"第99期（自　平成28年４月１日　至　平成28年12月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2016\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3033.0,"averageTemporaryStaff":603.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":38899000.0,"sharesOwendPercent":0.4741,"outstandingShares":null,"numberOfSubsidiary":36.0,"bps":1947.82,"equityRatio":0.703,"cashAndCashEquivalents":48688000000.0,"assets":218831000000.0,"currentAssets":142346000000.0,"fixedAsset":76484000000.0,"tangibleFixedAssets":18247000000.0,"intangibleFixedAssets":4798000000.0,"investmentAndOtherAssets":53438000000.0,"liabilities":65019000000.0,"currentLiabilities":54274000000.0,"shorTermDept":194000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10744000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":153811000000.0,"capitalStock":142132000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":146758000000.0,"treasuryStock":-12259000000.0,"valuationAndConversionAdjustments":11642000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":156761000000.0,"costOfSales":61238000000.0,"grossProfit":95522000000.0,"sgaExpenses":72596000000.0,"salaryAndBenefit":null,"depreciationAndSGA":741000000.0,"RDExpenses":7239000000.0,"operatingIncome":22925000000.0,"nonOperatingIncome":2724000000.0,"nonOperatingExpenses":1458000000.0,"interestExpense":38000000.0,"ordinaryProfit":24191000000.0,"extraordinaryGain":105000000.0,"extraordinaryLoss":1724000000.0,"incomeBeforeTax":22572000000.0,"incomeTaxes":6709000000.0,"netIncome":15863000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15863000000.0,"comprehensiveIncome":19474000000.0,"eps":201.31,"dilutedEps":201.03,"dividendPerShare":null,"per":36.4,"roe":0.107,"cashFlowFromOperatingActivities":22350000000.0,"depreciationAndCashflowFromOperatingActivities":2926000000.0,"cashFlowFromInvestingActivities":7039000000.0,"cashFlowFromFinancialActivities":-9162000000.0,"changesInCashAndCashEquivalents":20365000000.0,"列1":"asr","submitDate":"2018\/3\/29","stockCode":4967,"accountingYear":"第100期（自　平成29年１月１日　至　平成29年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3271.0,"averageTemporaryStaff":566.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":39025000.0,"sharesOwendPercent":0.4935,"outstandingShares":null,"numberOfSubsidiary":39.0,"bps":2102.49,"equityRatio":0.72,"cashAndCashEquivalents":55916000000.0,"assets":230989000000.0,"currentAssets":155058000000.0,"fixedAsset":75930000000.0,"tangibleFixedAssets":19024000000.0,"intangibleFixedAssets":4823000000.0,"investmentAndOtherAssets":52082000000.0,"liabilities":64740000000.0,"currentLiabilities":55215000000.0,"shorTermDept":506000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":9524000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":166249000000.0,"capitalStock":155728000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":159857000000.0,"treasuryStock":-11763000000.0,"valuationAndConversionAdjustments":10520000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":167479000000.0,"costOfSales":64359000000.0,"grossProfit":103119000000.0,"sgaExpenses":76830000000.0,"salaryAndBenefit":null,"depreciationAndSGA":718000000.0,"RDExpenses":7031000000.0,"operatingIncome":26289000000.0,"nonOperatingIncome":2528000000.0,"nonOperatingExpenses":1443000000.0,"interestExpense":35000000.0,"ordinaryProfit":27374000000.0,"extraordinaryGain":7000000.0,"extraordinaryLoss":2078000000.0,"incomeBeforeTax":25304000000.0,"incomeTaxes":7280000000.0,"netIncome":18023000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":18023000000.0,"comprehensiveIncome":16901000000.0,"eps":228.05,"dilutedEps":227.95,"dividendPerShare":null,"per":32.8,"roe":0.113,"cashFlowFromOperatingActivities":20007000000.0,"depreciationAndCashflowFromOperatingActivities":2964000000.0,"cashFlowFromInvestingActivities":-8062000000.0,"cashFlowFromFinancialActivities":-4285000000.0,"changesInCashAndCashEquivalents":7228000000.0,"列1":"asr","submitDate":"2019\/3\/28","stockCode":4967,"accountingYear":"第101期（自　平成30年１月１日　至　平成30年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.752,"cashAndCashEquivalents":null,"assets":220457000000.0,"currentAssets":141571000000.0,"fixedAsset":78886000000.0,"tangibleFixedAssets":19263000000.0,"intangibleFixedAssets":4733000000.0,"investmentAndOtherAssets":54889000000.0,"liabilities":54764000000.0,"currentLiabilities":47128000000.0,"shorTermDept":490000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7635000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":165693000000.0,"capitalStock":153863000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":160773000000.0,"treasuryStock":-14543000000.0,"valuationAndConversionAdjustments":11830000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":33735000000.0,"costOfSales":12448000000.0,"grossProfit":21287000000.0,"sgaExpenses":15999000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":5287000000.0,"nonOperatingIncome":178000000.0,"nonOperatingExpenses":246000000.0,"interestExpense":4000000.0,"ordinaryProfit":5219000000.0,"extraordinaryGain":3000000.0,"extraordinaryLoss":10000000.0,"incomeBeforeTax":5212000000.0,"incomeTaxes":1529000000.0,"netIncome":3683000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3683000000.0,"comprehensiveIncome":4992000000.0,"eps":46.65,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/10","stockCode":4967,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":38646000.0,"sharesOwendPercent":0.4944,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.743,"cashAndCashEquivalents":47573000000.0,"assets":219459000000.0,"currentAssets":143687000000.0,"fixedAsset":75772000000.0,"tangibleFixedAssets":20763000000.0,"intangibleFixedAssets":4094000000.0,"investmentAndOtherAssets":50914000000.0,"liabilities":56467000000.0,"currentLiabilities":48200000000.0,"shorTermDept":26000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":8267000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":162992000000.0,"capitalStock":153163000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":165292000000.0,"treasuryStock":-19762000000.0,"valuationAndConversionAdjustments":9828000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":73630000000.0,"costOfSales":26639000000.0,"grossProfit":46990000000.0,"sgaExpenses":35569000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3072000000.0,"operatingIncome":11421000000.0,"nonOperatingIncome":865000000.0,"nonOperatingExpenses":652000000.0,"interestExpense":8000000.0,"ordinaryProfit":11635000000.0,"extraordinaryGain":605000000.0,"extraordinaryLoss":655000000.0,"incomeBeforeTax":11585000000.0,"incomeTaxes":3383000000.0,"netIncome":8202000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":8202000000.0,"comprehensiveIncome":7509000000.0,"eps":104.26,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":7272000000.0,"depreciationAndCashflowFromOperatingActivities":1464000000.0,"cashFlowFromInvestingActivities":-3981000000.0,"cashFlowFromFinancialActivities":-11351000000.0,"changesInCashAndCashEquivalents":-8342000000.0,"列1":"q2r","submitDate":"2019\/8\/8","stockCode":4967,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.751,"cashAndCashEquivalents":null,"assets":222615000000.0,"currentAssets":149359000000.0,"fixedAsset":73256000000.0,"tangibleFixedAssets":20671000000.0,"intangibleFixedAssets":3913000000.0,"investmentAndOtherAssets":48671000000.0,"liabilities":55455000000.0,"currentLiabilities":47236000000.0,"shorTermDept":6000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":8219000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":167160000000.0,"capitalStock":157561000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":169690000000.0,"treasuryStock":-19762000000.0,"valuationAndConversionAdjustments":9598000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":117789000000.0,"costOfSales":43055000000.0,"grossProfit":74733000000.0,"sgaExpenses":54437000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":20296000000.0,"nonOperatingIncome":2193000000.0,"nonOperatingExpenses":1042000000.0,"interestExpense":12000000.0,"ordinaryProfit":21447000000.0,"extraordinaryGain":753000000.0,"extraordinaryLoss":691000000.0,"incomeBeforeTax":21509000000.0,"incomeTaxes":6264000000.0,"netIncome":15245000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15245000000.0,"comprehensiveIncome":14323000000.0,"eps":194.2,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/14","stockCode":4967,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3435.0,"averageTemporaryStaff":557.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":38956000.0,"sharesOwendPercent":0.4984,"outstandingShares":null,"numberOfSubsidiary":37.0,"bps":2208.94,"equityRatio":0.74,"cashAndCashEquivalents":56272000000.0,"assets":233398000000.0,"currentAssets":162712000000.0,"fixedAsset":70685000000.0,"tangibleFixedAssets":21180000000.0,"intangibleFixedAssets":3112000000.0,"investmentAndOtherAssets":46392000000.0,"liabilities":60740000000.0,"currentLiabilities":53433000000.0,"shorTermDept":19000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7307000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":172657000000.0,"capitalStock":161521000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":173650000000.0,"treasuryStock":-19762000000.0,"valuationAndConversionAdjustments":11136000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":168052000000.0,"costOfSales":64705000000.0,"grossProfit":103346000000.0,"sgaExpenses":76991000000.0,"salaryAndBenefit":null,"depreciationAndSGA":891000000.0,"RDExpenses":7110000000.0,"operatingIncome":26355000000.0,"nonOperatingIncome":2736000000.0,"nonOperatingExpenses":1239000000.0,"interestExpense":20000000.0,"ordinaryProfit":27851000000.0,"extraordinaryGain":982000000.0,"extraordinaryLoss":2029000000.0,"incomeBeforeTax":26804000000.0,"incomeTaxes":7665000000.0,"netIncome":19139000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19139000000.0,"comprehensiveIncome":19754000000.0,"eps":244.08,"dilutedEps":null,"dividendPerShare":null,"per":38.0,"roe":0.113,"cashFlowFromOperatingActivities":20089000000.0,"depreciationAndCashflowFromOperatingActivities":3731000000.0,"cashFlowFromInvestingActivities":-5072000000.0,"cashFlowFromFinancialActivities":-14581000000.0,"changesInCashAndCashEquivalents":356000000.0,"列1":"asr","submitDate":"2020\/3\/27","stockCode":4967,"accountingYear":"第102期（自　2019年１月１日　至　2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.768,"cashAndCashEquivalents":null,"assets":221873000000.0,"currentAssets":156311000000.0,"fixedAsset":65561000000.0,"tangibleFixedAssets":20015000000.0,"intangibleFixedAssets":3077000000.0,"investmentAndOtherAssets":42468000000.0,"liabilities":51440000000.0,"currentLiabilities":45864000000.0,"shorTermDept":8000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":5576000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":170432000000.0,"capitalStock":162138000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":174266000000.0,"treasuryStock":-19762000000.0,"valuationAndConversionAdjustments":8294000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":31911000000.0,"costOfSales":13689000000.0,"grossProfit":18222000000.0,"sgaExpenses":13347000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":4875000000.0,"nonOperatingIncome":324000000.0,"nonOperatingExpenses":157000000.0,"interestExpense":9000000.0,"ordinaryProfit":5042000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":97000000.0,"incomeBeforeTax":4946000000.0,"incomeTaxes":1204000000.0,"netIncome":3742000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3742000000.0,"comprehensiveIncome":901000000.0,"eps":47.89,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/5\/13","stockCode":4967,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":37071000.0,"sharesOwendPercent":0.4743,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.779,"cashAndCashEquivalents":64891000000.0,"assets":224989000000.0,"currentAssets":159869000000.0,"fixedAsset":65120000000.0,"tangibleFixedAssets":20374000000.0,"intangibleFixedAssets":3085000000.0,"investmentAndOtherAssets":41660000000.0,"liabilities":49809000000.0,"currentLiabilities":43797000000.0,"shorTermDept":12000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6011000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":175180000000.0,"capitalStock":166613000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":178742000000.0,"treasuryStock":-19762000000.0,"valuationAndConversionAdjustments":8566000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":66180000000.0,"costOfSales":27752000000.0,"grossProfit":38428000000.0,"sgaExpenses":28207000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3356000000.0,"operatingIncome":10220000000.0,"nonOperatingIncome":1101000000.0,"nonOperatingExpenses":292000000.0,"interestExpense":9000000.0,"ordinaryProfit":11029000000.0,"extraordinaryGain":2000000.0,"extraordinaryLoss":149000000.0,"incomeBeforeTax":10882000000.0,"incomeTaxes":2664000000.0,"netIncome":8218000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":8218000000.0,"comprehensiveIncome":5648000000.0,"eps":105.14,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":11969000000.0,"depreciationAndCashflowFromOperatingActivities":2203000000.0,"cashFlowFromInvestingActivities":182000000.0,"cashFlowFromFinancialActivities":-3232000000.0,"changesInCashAndCashEquivalents":8618000000.0,"列1":"q2r","submitDate":"2020\/8\/7","stockCode":4967,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.792,"cashAndCashEquivalents":null,"assets":227247000000.0,"currentAssets":164631000000.0,"fixedAsset":62615000000.0,"tangibleFixedAssets":20661000000.0,"intangibleFixedAssets":3089000000.0,"investmentAndOtherAssets":38865000000.0,"liabilities":47374000000.0,"currentLiabilities":41159000000.0,"shorTermDept":0.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6215000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":179872000000.0,"capitalStock":170995000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":183124000000.0,"treasuryStock":-19762000000.0,"valuationAndConversionAdjustments":8877000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":105049000000.0,"costOfSales":43790000000.0,"grossProfit":61259000000.0,"sgaExpenses":41743000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":19515000000.0,"nonOperatingIncome":1899000000.0,"nonOperatingExpenses":372000000.0,"interestExpense":13000000.0,"ordinaryProfit":21042000000.0,"extraordinaryGain":5000000.0,"extraordinaryLoss":184000000.0,"incomeBeforeTax":20863000000.0,"incomeTaxes":5605000000.0,"netIncome":15258000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15258000000.0,"comprehensiveIncome":12999000000.0,"eps":195.21,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/11\/11","stockCode":4967,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":3473.0,"averageTemporaryStaff":542.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":37313000.0,"sharesOwendPercent":0.4774,"outstandingShares":null,"numberOfSubsidiary":35.0,"bps":2335.93,"equityRatio":0.766,"cashAndCashEquivalents":61157000000.0,"assets":238366000000.0,"currentAssets":164225000000.0,"fixedAsset":74141000000.0,"tangibleFixedAssets":20821000000.0,"intangibleFixedAssets":12794000000.0,"investmentAndOtherAssets":40525000000.0,"liabilities":55783000000.0,"currentLiabilities":50107000000.0,"shorTermDept":13000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":5675000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":182583000000.0,"capitalStock":174941000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":187071000000.0,"treasuryStock":-19763000000.0,"valuationAndConversionAdjustments":7641000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":150514000000.0,"costOfSales":65248000000.0,"grossProfit":85265000000.0,"sgaExpenses":59322000000.0,"salaryAndBenefit":null,"depreciationAndSGA":872000000.0,"RDExpenses":7338000000.0,"operatingIncome":25943000000.0,"nonOperatingIncome":2346000000.0,"nonOperatingExpenses":563000000.0,"interestExpense":21000000.0,"ordinaryProfit":27726000000.0,"extraordinaryGain":265000000.0,"extraordinaryLoss":1356000000.0,"incomeBeforeTax":26635000000.0,"incomeTaxes":7430000000.0,"netIncome":19205000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19205000000.0,"comprehensiveIncome":15710000000.0,"eps":245.71,"dilutedEps":null,"dividendPerShare":null,"per":51.3,"roe":0.108,"cashFlowFromOperatingActivities":23986000000.0,"depreciationAndCashflowFromOperatingActivities":3837000000.0,"cashFlowFromInvestingActivities":-12656000000.0,"cashFlowFromFinancialActivities":-6019000000.0,"changesInCashAndCashEquivalents":4884000000.0,"列1":"asr","submitDate":"2021\/3\/26","stockCode":4967,"accountingYear":"第103期（自　2020年1月1日　至　2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.795,"cashAndCashEquivalents":null,"assets":233975000000.0,"currentAssets":161127000000.0,"fixedAsset":72848000000.0,"tangibleFixedAssets":20903000000.0,"intangibleFixedAssets":13230000000.0,"investmentAndOtherAssets":38714000000.0,"liabilities":47965000000.0,"currentLiabilities":41973000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":5991000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":186010000000.0,"capitalStock":175208000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":187338000000.0,"treasuryStock":-19763000000.0,"valuationAndConversionAdjustments":10801000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":30269000000.0,"costOfSales":12477000000.0,"grossProfit":17791000000.0,"sgaExpenses":13102000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":4689000000.0,"nonOperatingIncome":582000000.0,"nonOperatingExpenses":80000000.0,"interestExpense":2000000.0,"ordinaryProfit":5192000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":15000000.0,"incomeBeforeTax":5176000000.0,"incomeTaxes":1548000000.0,"netIncome":3628000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3628000000.0,"comprehensiveIncome":6787000000.0,"eps":46.42,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/5\/13","stockCode":4967,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":36626000.0,"sharesOwendPercent":0.4686,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.796,"cashAndCashEquivalents":72108000000.0,"assets":239352000000.0,"currentAssets":167887000000.0,"fixedAsset":71465000000.0,"tangibleFixedAssets":21279000000.0,"intangibleFixedAssets":12841000000.0,"investmentAndOtherAssets":37344000000.0,"liabilities":48799000000.0,"currentLiabilities":41974000000.0,"shorTermDept":1000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6824000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":190553000000.0,"capitalStock":179462000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":191592000000.0,"treasuryStock":-19763000000.0,"valuationAndConversionAdjustments":11091000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":67052000000.0,"costOfSales":27430000000.0,"grossProfit":39621000000.0,"sgaExpenses":29381000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3426000000.0,"operatingIncome":10240000000.0,"nonOperatingIncome":1001000000.0,"nonOperatingExpenses":150000000.0,"interestExpense":9000000.0,"ordinaryProfit":11091000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":53000000.0,"incomeBeforeTax":11037000000.0,"incomeTaxes":3156000000.0,"netIncome":7881000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":7881000000.0,"comprehensiveIncome":11331000000.0,"eps":100.84,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":9773000000.0,"depreciationAndCashflowFromOperatingActivities":1871000000.0,"cashFlowFromInvestingActivities":4142000000.0,"cashFlowFromFinancialActivities":-3459000000.0,"changesInCashAndCashEquivalents":10951000000.0,"列1":"q2r","submitDate":"2021\/8\/6","stockCode":4967,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0},{"edinetCode":"E01047","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.802,"cashAndCashEquivalents":null,"assets":242375000000.0,"currentAssets":171709000000.0,"fixedAsset":70666000000.0,"tangibleFixedAssets":21506000000.0,"intangibleFixedAssets":12617000000.0,"investmentAndOtherAssets":36542000000.0,"liabilities":48028000000.0,"currentLiabilities":41413000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6614000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":194347000000.0,"capitalStock":183571000000.0,"capital":3450000000.0,"capitalSurplus":4183000000.0,"accumulatedEarnings":195702000000.0,"treasuryStock":-19764000000.0,"valuationAndConversionAdjustments":10775000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":107658000000.0,"costOfSales":44249000000.0,"grossProfit":63409000000.0,"sgaExpenses":43982000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":19426000000.0,"nonOperatingIncome":1838000000.0,"nonOperatingExpenses":249000000.0,"interestExpense":13000000.0,"ordinaryProfit":21016000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":124000000.0,"incomeBeforeTax":20892000000.0,"incomeTaxes":6009000000.0,"netIncome":14883000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":14883000000.0,"comprehensiveIncome":18017000000.0,"eps":190.42,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/11\/11","stockCode":4967,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E01047","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3450,"settlementDate":"2022\/12\/31","submitterName":"小林製薬株式会社","submitterNameEnglish":"KOBAYASHI PHARMACEUTICAL  CO.,LTD.","submitterNameKana":"コバヤシセイヤクカブシキガイシャ","location":"大阪市中央区道修町４丁目４番１０号","industory":"化学","corporateNumber":4120000000000.0}]